Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schleutker, J.
Right arrow Articles by Kallioniemi, O.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schleutker, J.
Right arrow Articles by Kallioniemi, O.-P.
Clinical Cancer Research Vol. 6, 4810-4815, December 2000
© 2000 American Association for Cancer Research

Molecular Oncology, Markers, Clinical Correlates

A Genetic Epidemiological Study of Hereditary Prostate Cancer (HPC) in Finland: Frequent HPCX Linkage in Families with Late-onset Disease1

Johanna Schleutker2,3, Mika Matikainen3, Jeffrey Smith3, Pasi Koivisto, Agnes Baffoe-Bonnie, Tommi Kainu, Elizabeth Gillanders, Risto Sankila, Eero Pukkala, John Carpten, Dietrich Stephan, Teuvo Tammela, Michael Brownstein, Joan Bailey-Wilson, Jeffrey Trent and Olli-P. Kallioniemi

Cancer Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland 20892 [J. Sc., J. Sm., T. K., E. G., J. C., D. S., M. B., J. T., O-P. K.]; Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, 33521 Tampere, Finland [J. Sc., M. M., P. K.]; Inherited Disease Research Branch, National Human Genome Research Institute, NIH, Baltimore, Maryland 21224 [A. B-B., J. B-W.]; Finnish Cancer Registry, 00170 Helsinki, Finland [R. S., E. P.]; Division of Urology, Tampere University Hospital, 33521 Tampere, Finland [T. T.]; and Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 [A. B-B.]

Several predisposition loci for hereditary prostate cancer (HPC) have been suggested, including HPC1 at 1q24-q25 (OMIM #601518) and HPCX at Xq27-q28 (OMIM #300147). Genetically homogeneous populations, such as that of Finland, and distinct subsets of families may help to minimize the genetic heterogeneity that complicates the genetic dissection of complex traits. Here, the role of the HPC1 and HPCX loci in a series of Finnish prostate cancer families was studied, especially in subgroups of families defined by age, number of affected cases, and the mode of disease transmission. DNA samples were collected from 57 Finnish HPC families with at least two living prostate cancer patients. Linkage analysis was carried out with 39 microsatellite markers for the HPC1 region and 22 markers for the HPCX region. The maximum two-point LOD score for the HPCX was 2.05 (marker DXS1205, at {theta} = 0.14), whereas HPC1 LOD scores were all negative. In HOMOG3R analyses, significant evidence of heterogeneity was observed. Subgroup analyses performed to explore the nature of this heterogeneity indicated that families with no male-to-male (NMM) transmission and a late age of diagnosis (>65 years) accounted for most of the HPCX-linked cases. The maximum HPCX LOD score in this subgroup was 3.12 ({theta} = 0.001). Nonparametric sibling pair analyses gave a peak LOD score of 3.04 (P < 0.000093) for the NMM transmission subgroup. No subgroup showed any positivity for HPC1. This study suggests that the HPCX-linked prostate cancer families represent a distinct subgroup characterized by NMM transmission of disease and late age of diagnosis.




This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
V.A. Westbrook, P.D. Schoppee, G.R. Vanage, K.L. Klotz, A.B. Diekman, C.J. Flickinger, M.A. Coppola, and J.C. Herr
Hominoid-specific SPANXA/D genes demonstrate differential expression in individuals and protein localization to a distinct nuclear envelope domain during spermatid morphogenesis
Mol. Hum. Reprod., November 1, 2006; 12(11): 703 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. J. Hebbring, H. Fredriksson, K. A. White, C. Maier, C. Ewing, S. K. McDonnell, S. J. Jacobsen, J. Cerhan, D. J. Schaid, T. Ikonen, et al.
Role of the nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 935 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Mononen, E. H. Seppala, P. Duggal, V. Autio, T. Ikonen, P. Ellonen, J. Saharinen, J. Saarela, M. Vihinen, T. L.J. Tammela, et al.
Profiling Genetic Variation along the Androgen Biosynthesis and Metabolism Pathways Implicates Several Single Nucleotide Polymorphisms and Their Combinations as Prostate Cancer Risk Factors
Cancer Res., January 15, 2006; 66(2): 743 - 747.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. M. Gillanders, J. Xu, B.-l. Chang, E. M. Lange, F. Wiklund, J. E. Bailey-Wilson, A. Baffoe-Bonnie, M. Jones, D. Gildea, E. Riedesel, et al.
Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes
J Natl Cancer Inst, August 18, 2004; 96(16): 1240 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. J. Schaid
The complex genetic epidemiology of prostate cancer
Hum. Mol. Genet., April 1, 2004; 13(90001): R103 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. H. Seppala, T. Ikonen, V. Autio, A. Rokman, N. Mononen, M. P. Matikainen, T. L. J. Tammela, and J. Schleutker
Germ-Line Alterations in MSR1 Gene and Prostate Cancer Risk
Clin. Cancer Res., November 1, 2003; 9(14): 5252 - 5256.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
T Ikonen, M P Matikainen, K Syrjakoski, N Mononen, P A Koivisto, A Rokman, E H Seppala, O-P Kallioniemi, T L J Tammela, and J Schleutker
BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland
J. Med. Genet., August 1, 2003; 40(8): e98 - 98.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Marchesani, A. Hakkarainen, T.-P. Tuomainen, J. Kaikkonen, E. Pukkala, P. Uimari, E. Seppala, M. Matikainen, O.-P. Kallioniemi, J. Schleutker, et al.
New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men
J Natl Cancer Inst, June 4, 2003; 95(11): 812 - 818.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
R Lehtonen, M Kiuru, A Rokman, T Ikonen, J M Cunningham, D J Schaid, M Matikainen, N N Nupponen, A Karhu, O-P Kallioniemi, et al.
No fumarate hydratase (FH) mutations in hereditary prostate cancer
J. Med. Genet., March 1, 2003; 40(3): e19 - 19.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Simard, M. Dumont, P. Soucy, and F. Labrie
Perspective: Prostate Cancer Susceptibility Genes
Endocrinology, June 1, 2002; 143(6): 2029 - 2040.
[Full Text] [PDF]

Home page
 JCOHome page
T. Makinen, T. L.J. Tammela, U.-H. Stenman, L. Maattanen, S. Rannikko, J. Aro, H. Juusela, M. Hakama, and A. Auvinen
Family History and Prostate Cancer Screening With Prostate-Specific Antigen
J. Clin. Oncol., June 1, 2002; 20(11): 2658 - 2663.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Rokman, T. Ikonen, N. Mononen, V. Autio, M. P. Matikainen, P. A. Koivisto, T. L. J. Tammela, O.-P. Kallioniemi, and J. Schleutker
ELAC2/HPC2 Involvement in Hereditary and Sporadic Prostate Cancer
Cancer Res., August 1, 2001; 61(16): 6038 - 6041.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2000 by the American Association for Cancer Research.